siRNA, Anti-ATP4A, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT01333WQ-2OMe)
The product SIRGT01333WQ-2OMe is a type of small interfering RNA (siRNA) that targets ATP4A gene and regulates the expression of gene. The siRNA interferes with the expression of ATP4A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_000704.2 |
| Alternative Names | ATP6A |
| Related Diseases | Familial Gastric Type 1 Neuroendocrine Tumor, Functional Gastric Disease |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT02333WQ-2F | ATP4A | Human | 2ʹ-deoxy-2ʹ-fluoro (2'-F) | ||
| SIRGT03333WQ-2MOE | ATP4A | Human | 2'-O-methoxyethyl (2'-MOE) | ||
| SIRGT04333WQ-LNA | ATP4A | Human | Locked Nucleic Acid (LNA) | ||
| SIRGT01333WQ-RB | ATP4A | Human | Ribo-modified | ||
| SIRGT02333WQ-BB | ATP4A | Human | Backbone-modified |
